Legal Opinion
1. Approval and Authorization of the Adjustment
According to the legal opinion issued by the law firm, the adjustment of this plan has been approved as follows:
002773SZSE
Legal Opinion on the Adjustment of the Exercise Price for Chengdu Kanghong Pharmaceutical Group Co., Ltd.'s 2022 Stock Appreciation Rights Incentive Plan
✨ AI Summary
This document provides a legal opinion regarding the adjustment of the exercise price for the 2022 stock appreciation rights incentive plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd. The adjustments were approved during board meetings held on various dates in 2022. The final exercise price is set at 12.34 CNY per share, effective from June 9, 2026.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.